Maureen Early Email

VP Commercial . Rénibus Therapeutics

Current Roles

Employees:
47
Revenue:
$4.7M
About
Rénibus Therapeutics is a clinical-stage biotech company dedicated to transforming the cardiorenal disease treatment paradigm by focusing on the prevention and treatment of kidney disease. The company’s portfolio includes RBT-1 for prevention of acute kidney injury, RBT-2 for treatment of chronic kidney disease, and RBT-3 for treatment of iron deficiency anemia and platinum-based kidney toxicity.
Rénibus Therapeutics Address
181 Grand Ave
Southlake, TX
United States
Rénibus Therapeutics Email

Past Companies

Rénibus Therapeutics IncVP Commercial
The iTero GroupPrincipal
Synthetic Biologics, Inc.Vice President, Commercial